Novel water-based antiseptic lotion demonstrates rapid, broad-spectrum kill compared with alcohol antiseptic  by Czerwinski, Steven E. et al.
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Summary  A  novel  alcohol-based  antiseptic  and  a  novel  water-based  antiseptic
lotion,  both  with  a  synergistic  combination  of  antimicrobial  ingredients  containing
0.2%  benzethonium  chloride,  were  evaluated  using  the  standard  time-kill  method
against  25  FDA-speciﬁed  challenge  microorganisms.  The  purpose  of  the  testing  was
to  determine  whether  a  non-alcohol  product  could  have  equivalent  rapid  and  broad-
spectrum  kill  to  a  traditional  alcohol  sanitizer.
Both  the  alcohol-  and  water-based  products  showed  rapid  and  broad-spectrum
antimicrobial  activity.  The  average  15-s  kill  was  99.999%  of  the  challenge  organism
for  the  alcohol-based  antiseptic  and  99.971%  for  the  water-based  antiseptic.  The
alcohol-based  product  demonstrated  100%  of  peak  efﬁcacy  (60  s)  within  the  ﬁrst
15  s,  whereas  the  water-based  product  showed  99.97%.  The  novel  alcohol-based
antiseptic  reduced  concentrations  of  100%  of  organisms  by  99.999%,  whereas  the
water-based  antiseptic  lotion  showed  the  same  reduction  for  96%  of  organisms.
A  novel  water-based  antiseptic  product  demonstrated  equivalent  rapid,  broad-
spectrum  antimicrobial  activity  to  an  alcohol-based  sanitizer  and  provided  additional
beneﬁts  of  reduced  irritation,  persistent  effect,  and  greater  efﬁcacy  against
common  viruses.  The  combination  of  rapid,  broad-spectrum  immediate  kill  and  per-
sistent  efﬁcacy  against  pathogens  may  have  signiﬁcant  clinical  beneﬁt  in  limiting
the  spread  of  disease.
©  2014  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
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ndustry  standard  for  waterless  hand  antisep-
is. Products  with  greater  than  60%  alcohol  are
nces. Published by Elsevier Ltd. All rights reserved.
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currently  the  only  sanitizers  recommended  for  use
in hospitals  by  the  CDC  [1].  The  beneﬁt  of  alcohol
in this  concentration  is  the  rapid  kill  of  a broad
spectrum of  bacteria,  including  gram-positive  and
gram-negative  bacteria.
However,  there  are  signiﬁcant  intrinsic  limita-
tions and  drawbacks  to  the  use  of  alcohol-based
sanitizers.  Studies  have  shown  that  using  alcohol-
based  sanitizers  in  hospitals  is  equivalent  to
handwashing  alone  but  does  not  result  in  the  hoped-
for reduction  in  hospital-acquired  infections  (HAI)
[2,3],  which  currently  afﬂict  1  in  20  hospitalized
patients and  kill  nearly  90,000  Americans  each  year
[4].  The  most  important  limitation  of  alcohol-based
sanitizers is  the  drying  effect  on  the  hands,  which
can reduce  hand  hygiene  compliance.  Additional
limitations include  the  lack  of  persistent  activity
against  pathogens  and  a  relative  ineffectiveness
against many  viruses.
Alcohol-based  products  dry  the  hands  with
repeated use,  often  leaving  the  skin  of  healthcare
workers cracked  and  painful.  Multiple  studies  have
demonstrated  that  even  trained  healthcare  work-
ers follow  hand  hygiene  protocols  only  40—50%  of
the time,  in  part  because  of  the  drying  nature  of
alcohol-based  products  [5]. Benzethonium  chloride
(BZT) has  been  shown  to  increase  moisture  levels
in the  skin  with  repeated  use,  whereas  every  other
antimicrobial  agent  tested  was  shown  to  dry  the
skin [5].  In  another  dermal  irritation  study,  subjects
used a  product  with  0.2%  BZT  100  times  daily  for  ﬁve
days without  reporting  any  skin  irritation  [6].
This failure  to  comply  with  hand  hygiene  pro-
tocols is  clinically  relevant  because  alcohol-based
products are  only  effective  until  they  evaporate,
typically approximately  15  s.  After  this  time,  hands
may become  immediately  recontaminated  if  they
come in  contact  with  tainted  surfaces,  as  there  is
no persistent  activity.  Failures  in  hand  hygiene  com-
pliance allows  microorganisms  to  be  transmitted  to
patients and  staff.
Finally,  alcohol-based  sanitizers  are  largely  inef-
fective against  non-enveloped  viruses  [7], which
are a  signiﬁcant  cause  of  disease  in  healthcare
settings and  in  homes  [8]. Non-enveloped  viruses
include  the  Norovirus  (leading  cause  of  acute  gas-
troenteritis  or  the  ‘‘stomach  ﬂu’’),  rhinoviruses
(common colds),  rotavirus  (severe  diarrhea,  espe-
cially in  children),  adenoviruses  (tonsillitis  and
conjunctivitis),  and  Hepatitis  A,  among  others.
Studies  have  shown  that  0.2%  BZT,  as  found  in
the water-based  antiseptic  lotion  evaluated  in  this
study, effectively  eliminates  more  than  99%  of  HIV,
Herpes, and  Inﬂuenzae  viruses  on  contact  [6].
The relative  ineffectiveness  of  alcohol  against
these viruses  has  major  clinical  signiﬁcance.  One
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f  the  most  studied  viruses  in  clinical  settings  is
orovirus.  In  a  study  using  the  ﬁngerpads  of  human
olunteers,  use  of  an  alcohol-based  sanitizer  was
ound to  be  less  effective  than  rinsing  with  water
lone against  Norovirus,  reducing  its  concentration
nly by  0.14—0.34  log  [9]. In  a survey  of  nurs-
ng homes,  researchers  found  that  facilities  that
elied on  alcohol-based  products  instead  of  hand-
ashing  were  more  than  six  times  as  likely  to  have
 Norovirus  outbreak  [10]. Cruise  ships,  another
losed environment  where  Norovirus  is  a  preva-
ent pathogen,  have  averaged  16  outbreaks  a  year,
espite the  widespread  use  of  alcohol-based  sani-
izers [11].
The  clinical  beneﬁt  of  a  persistent  non-alcohol
anitizer has  been  evaluated  in  elementary  school
ettings.  When  students  were  given  access  to  an
lcohol-based  product,  illness-related  absenteeism
as decreased  by  19%  in  one  study  and  unaf-
ected in  a second  [12,13].  In  contrast,  a  quaternary
mmonium compound  product  with  persistence,  in
he same  class  as  BZT,  was  demonstrated  to  reduce
llness  absenteeism  by  42%  [14].
The  purpose  of  this  research  is  to  investigate  the
apid and  broad-spectrum  efﬁcacy  of  a novel  line
f alcohol-  and  water-based  antiseptic  products
ontaining BZT  that  seek  to  address  the  primary  lim-
tations of  traditional  alcohol-based  products.  The
roducts tested  were  an  alcohol-based  antiseptic
ethanol, 76%  (v/v))  and  a water-based  antisep-
ic lotion  (BZT,  0.2%).  Both  products  have  been
emonstrated to  have  persistent  activity  against
ram-positive  and  gram-negative  microorganisms,
howing a reduction  of  at  least  97%  against  tran-
ient Staphylococcus  aureus  and  Escherichia  coli  1  h
ost-application  in  in  vitro  testing  and  reductions
f approximately  90%  in  the  same  in  vitro  model
 h post-application  [15]. Both  of  the  antiseptics
ere also  tested  using  the  ﬁngerpad  method  against
he standard  Norovirus  surrogate,  showing  a 3.5  log
eduction (99.97%)  on  contact  [16].
A water-based,  0.2%  BZT  antiseptic  lotion
ddresses many  of  the  clinical  issues  raised  by
lcohol-based  sanitizers.  Persistent  antimicrobial
ctivity can  help  prevent  recontamination  of  hands,
educed  irritation  may  increase  hand  hygiene
ompliance, and  efﬁcacy  against  common  viruses
ay prevent  cross-contamination  of  viral  infec-
ions.
This  study  used  an  In  Vitro  Time-Kill  protocol
o evaluate  the  test  products  when  challenged
ith 25  different  microorganism  species  (Microbi-
logics Inc.,  St.  Cloud,  MN)  as  described  in  the
DA-Tentative  Final  Monograph  (FDA-TFM)  [17].  By
valuating an  alcohol-based  and  a water-based
roduct using  the  same  test  and  time  points,  this
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Table  1  Time-kill  testing  results.
Organism  Antiseptic  Antiseptic  lotion
Acinetobacter  baumannii  (ATCC
#19606)
15  s  >6.57  (99.9999%)  >6.57  (99.9999%)
30  s  >6.57  (99.9999%)  >6.57  (99.9999%)
60  s  >6.57  (99.9999%)  >6.57  (99.9999%)
Bacteroides  fragilis  (ATCC#  25285) 15  s >7.22 (99.9999%) 3.87  (99.9864%)
30  s >7.22 (99.9999%) 6.92  (99.9999%)
60  s >7.22 (99.9999%) 3.92  (99.988%)
Candida  albicans  (ATCC#  10231)  15  s  >6.16  (99.9999%)  2.17  (99.3218%)
30  s  >6.16  (99.9999%)  2.75  (99.8208%)
60  s  >6.16  (99.9999%)  3.65  (99.9777%)
Candida  tropicalis  (ATCC  #750)  15  s  >6.14  (99.9999%)  4.14  (99.9927%)
30  s  >6.14  (99.9999%)  >6.14  (99.9999%)
60  s  >6.14  (99.9999%)  >6.14  (99.9999%)
Enterobacter  aerogenes  (ATCC
#13048)
15 s  >6.27  (99.9999%)  >6.27  (99.9999%)
30  s  >6.27  (99.9999%)  >6.27  (99.9999%)
60  s  >6.27  (99.9999%)  >6.27  (99.9999%)
Enterococcus  faecalis  (ATCC#
29212)
15 s  >6.20  (99.9999%)  5.38  (99.9996%)
30  s  >6.20  (99.9999%)  >6.20  (99.9999%)
60  s >6.20 (99.9999%)  >6.20  (99.9999%)
Enterococcus  faecium  (ATCC  #6057) 15  s >5.90 (99.9999%)  >5.90  (99.9999%)
30  s >5.90 (99.9999%)  >5.90  (99.9999%)
60  s >5.90 (99.9999%) >5.90  (99.9999%)
Escherichia  coli  (ATCC  #11229) 15  s  >6.14  (99.9999%)  >6.14  (99.9999%)
30  s >6.14 (99.9999%) >6.14  (99.9999%)
60  s >6.14 (99.9999%) >6.14  (99.9999%)
Escherichia  coli  (ATCC  #25922) 15  s >5.27 (99.9995%) >5.27  (99.9995%)
30  s >5.27 (99.9995%) >5.27  (99.9995%)
60  s >5.27 (99.9995%) >5.27  (99.9995%)
Haemophilus  inﬂuenzae  (ATCC
#33930)
15 s >6.23 (99.9999%) >6.23  (99.9999%)
30  s >6.23 (99.9999%) >6.23  (99.9999%)
60  s  >6.23  (99.9999%)  >6.23  (99.9999%)
Klebsiella  oxytoca  (ATCC  #13182)  15  s  >6.17  (99.9999%)  >6.17  (99.9999%)
30  s  >6.17  (99.9999%)  >6.17  (99.9999%)
60  s  >6.17  (99.9999%)  >6.17  (99.9999%)
Klebsiella  pneumoniae  (ATCC
#4352)
15 s  >6.17  (99.9999%)  >6.17  (99.9999%)
30  s  >6.17  (99.9999%)  >6.17  (99.9999%)
60  s  >6.17  (99.9999%)  >6.17  (99.9999%)
Micrococcus  luteus  (ATCC  #7468)  15  s  >5.40  (99.9996%)  >5.40  (99.9996%)
30  s  >5.40  (99.9996%)  >5.40  (99.9996%)
60  s  >5.40  (99.9996%)  >5.40  (99.9996%)
Proteus  mirabilis  (ATCC  #7002)  15  s  >6.08  (99.9999%)  >6.08  (99.9999%)
30  s  >6.08  (99.9999%)  >6.08  (99.9999%)
60  s  >6.08  (99.9999%)  >6.08  (99.9999%)
Pseudomonas  aeruginosa  (ATCC
#15442)
15  s  >6.29  (99.9999%)  >6.29  (99.9999%)
30  s  >6.29  (99.9999%)  >6.29  (99.9999%)
60  s  >6.29  (99.9999%)  >6.29  (99.9999%)
Pseudomonas  aeruginosa  (ATCC
#27853)
15  s  >5.92  (99.9999%)  >5.92  (99.9999%)
30  s  >5.92  (99.9999%)  >5.92  (99.9999%)
60  s  >5.92  (99.9999%)  >5.92  (99.9999%)
Serratia  marcescens  (ATCC  #14756)  15  s  >6.48  (99.9999%)  5.63  (99.9998%)
30  s  >6.48  (99.9999%)  >6.48  (99.9999%)
60  s >6.48 (99.9999%)  >6.48  (99.9999%)
Staphylococcus  aureus  (ATCC
#6538)
15 s >6.11 (99.9999%)  4.09  (99.9919%)
30  s >6.11 (99.9999%)  >6.11  (99.9999%)
60  s  >6.11  (99.9999%)  >6.11  (99.9999%)
Staphylococcus  aureus  (ATCC
#29212)
15 s  >5.56  (99.9997%)  >5.56  (99.9997%)
30  s  >5.56  (99.9997%)  >5.56  (99.9997%)
60  s  >5.56  (99.9997%)  >5.56  (99.9997%)
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Table  1  (Continued)
Organism  Antiseptic  Antiseptic  lotion
Staphylococcus  epidermidis  (ATCC
#12228)
15 s  >5.45  (99.9996%)  >5.45  (99.9996%)
30  s  >5.45  (99.9996%)  >5.45  (99.9996%)
60  s >5.45 (99.9996%) >5.45  (99.9996%)
Staphylococcus  haemolyticus
(ATCC  #29970)
15 s >5.05 (99.9991%) >5.05  (99.9991%)
30  s  >5.05  (99.9991%)  >5.05  (99.9991%)
60  s  >5.05  (99.9991%)  >5.05  (99.9991%)
Staphylococcus  hominis  (ATCC
#27844)
15 s  >4.95  (99.9989%)  >4.95  (99.9989%)
30  s  >4.95  (99.9989%)  >4.95  (99.9989%)
60  s  >4.95  (99.9989%)  >4.95  (99.9989%)
Staphylococcus  saprophyticus
(ATCC  #35552)
15 s  >5.88  (99.9999%)  >5.88  (99.9999%)
30  s >5.88 (99.9999%)  >5.88  (99.9999%)
60  s  >5.88  (99.9999%)  >5.88  (99.9999%)
Streptococcus  pneumoniae  (ATCC
#6303)
15  s  >6.29  (99.9999%)  >6.29  (99.9999%)
30  s  >6.29  (99.9999%)  3.05  (99.9100%)
60  s  >6.29  (99.9999%)  4.93  (99.9988%)
Streptococcus  pyogenes  (ATCC
#19615)
15 s  >6.11  (99.9999%)  >6.11  (99.9999%)
30  s >6.11 (99.9999%) >6.11  (99.9999%)
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study  determined  whether  the  water-based  product
can have  the  same  rapid,  broad-spectrum  efﬁcacy
as an  alcohol-based  sanitizer.
Materials and methods
The  products  were  evaluated  according  to  the
standard Time-Kill  protocol  and  against  25  differ-
ent microorganisms  (Table  1) as  speciﬁed  in  the
FDA-TFM.  The  products  tested  were  an  alcohol-
based antiseptic  (Zylast  Antiseptic,  76%  ethanol,
Innovative  BioDefense,  Inc.)  and  a  water-based
antiseptic lotion  with  a  synergistic  combination
ingredients centered  on  BZT  (Zylast  Antiseptic
Lotion, 0.2%  BZT,  Innovative  BioDefense,  Inc.).  Each
test product  was  evaluated  at  a  99%  concentra-
tion, and  the  percent  and  log  reductions  were
determined following  exposure  times  of  15,  30,
and 60  s.  All  agar  plating  was  performed  in  dupli-
cate. A  combination  of  clinical  isolates  and  lab
strains of  organisms  were  used  in  the  experiment.
Initial inoculum  count  was  targeted  at  1  × 109
for  all  organisms,  and  ranged  from  8.95  ×  107 to
1.65 ×  1010,  with  variations  due  to  cell  size  and
preparation.
Neutralization studies  of  each  test  product  were
performed  versus  Bacteroides  fragilis,  E.  coli,  S.
aureus, and  Streptococcus  pneumoniae  to  ensure
the neutralizing  solution  employed  (Butterﬁeld’s
Phosphate Buffer  solution  with  product  neutraliz-
ers) was  effective  and  non-toxic  to  each  of  the
representative challenge  species.
The following  data  were  evaluated:
e
m
(
a>6.11 (99.9999%)  >6.11  (99.9999%)
.  The  percentage  kill  across  all  organisms  was
averaged  and  compared  between  the  alcohol-
based antiseptic  and  the  water-based  antiseptic
lotion.
. The  number  of organisms  (out  of  the  25  tested)
that showed  a reduction  of  greater  than  or  equal
to 99.99%  was  compared.
.  The  percentage  of  overall  antimicrobial  effect
occurring in  the  ﬁrst  15  s  was  evaluated.  This
outcome was  analyzed  by  comparing  the  time-
kill results  in  the  ﬁrst  15  s with  the  results  after
60 s  of  exposure.
A two-sample  t-test  was  used  to  evalu-
te whether  there  is  a statistically  signiﬁcant
ifference between  the  15-s  kill  of  the  alcohol-
ased antiseptic  and  the  water-based  antiseptic
otion.
esults and discussion
he  alcohol-based  antiseptic  performed  as
xpected against  the  25  different  microorgan-
sm strains  (Table  1),  eliminating  at  least  99.999%
f all  organisms  tested  within  15  s.  There  was  no
ifference  in  efﬁcacy  between  the  15  and  60-s  time
oints,  indicating  that  100%  of the  antimicrobial
ctivity took  place  in  the  ﬁrst  15  s.
The water-based  antiseptic  lotion  was  also  highlyffective  against  the  tested  strains,  destroying
ore than  99.99%  of  24  of  25  organisms  within  15  s
Table  2).  Against  the  23  bacterial  strains  only,  the
ntiseptic lotion  averaged  a 99.999%  kill  within  the
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Table  2  Comparison  of  alcohol  and  non-alcohol  product.
Antiseptic  (76%  ethanol,  v/v)  Antiseptic  lotion  (0.2%  BZT)  Difference
Average  kill  at  15  s  99.9998%  99.9715%  0.028%
Average  kill  at  30  s  99.9998%  99.8990%  0.011%
Average  kill  at  60  s  99.9998%  99.9988%  0.001%
Percent  of  total  effect
achieved/ﬁrst  15  sa
100% 99.97% 0.03%
a Calculated as (% reduction at 15 s)/(% reduction at 60 s).
Table  3  Comparison  against  alcohol-only  product  (AvagardTM D)  at  15  s.
Avagard  D  sanitizer
(61%  ethanol)
Antiseptic
(76% ethanol)
Antiseptic  lotion
(0.2%  BZT)
S.  aureus  (ATCC  #6538)  99.1%  99.9997%  99.9997%
S.  epidermis  (ATCC  #12228)  >99.9%  99.9996%  99.9996%
K.  pneumoniae  (ATCC  #4352)  >99.9%  99.9999%  99.9999%
P.  aeruginosa  (ATCC  #27853)  >99.9%  99.9999%  99.9999%
E.  coli  (ATCC  #11229) >99.9%  99.9999%  99.9999%
S.  pneumoniae  (ATCC  #6303) >99.9% 99.9999%  99.9999%
S.  pyogenes  (ATCC  #19615) 98.0%  99.9999%  99.9999%
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iS.  marcescens  (ATCC  #14756) >99.9%
E.  faecalis  (ATCC  #29212) >99.9%  
rst  15  s  (Table  2).  In  the  analysis  of  time  of  kill,
9.97% of  the  antimicrobial  effect  was  achieved
ithin the  ﬁrst  15  s  of  contact  compared  with  the
0-s time  point.
Because the  testing  uses  a  standard  protocol,
esults can  be  evaluated  against  products  that  con-
ain ethanol  alone  to  compare  the  immediate  kill  of
he test  products  against  a  standard  alcohol  product
Table  3)  [18].
onclusion
he  alcohol-based  antiseptic  and  water-based  anti-
eptic lotion  performed  very  similarly  against  the
tandard  FDA-speciﬁed  panel  of  microorganisms  by
apid and  broad-spectrum  kill  analyses.  There  was
n average  difference  in  efﬁcacy  of  less  than  0.03%
fter 15  s  and  0.001%  after  60  s.  Both  products
chieved the  vast  majority  of  their  reduction  —
00% for  the  alcohol-based  antiseptic,  99.97%  for
he water-based  antiseptic  lotion  —  within  the  ﬁrst
5 s  of  contact.
Using  a  two-sample  t-test,  the  average  reduc-
ion in  the  ﬁrst  15  s  of  contact  was  analyzed.
he test  statistic  (t)  was  calculated  to  be  0.02653
ith 48  degrees  of  freedom,  yielding  a  p-value
f 0.29.  Thus,  the  difference  in  performance  at
5 s  between  the  alcohol-based  antiseptic  and
he water-based  antiseptic  lotion  was  not  statis-
ically signiﬁcant  based  on  a  p-value  threshold  of
.05.
k
k
p
e99.9999%  99.9998%
99.9999%  99.9996%
The  only  organism  that  was  not  reduced  by
9.99% by  the  antiseptic  lotion  within  15  s  was
andida albicans, a fungal  yeast,  with  a 99.32%
ill. At  60  s of  exposure,  the  reduction  was  99.98%.
enzethonium  chloride  and  quaternary  ammo-
ium  compounds  are  considered  highly  effective
gainst fungi,  but  the  thicker  cell  wall,  larger
ell, and  more  organized  cellular  structure  may
low the  antimicrobial  activity  in  this  time-kill  test
ompared  with  bacteria.
This  testing  has  demonstrated  that  the  immedi-
te, broad-spectrum  kill  proﬁle  is  almost  identical
etween the  alcohol-based  antiseptic  and  the
ater-based  antiseptic  lotion.  Results  of  this  time-
ill testing  eliminate  the  concern  that  a non-alcohol
roduct cannot  have  the  same  rapid  antimicrobial
eneﬁts as  an  alcohol-based  sanitizer.
Furthermore,  this  time-kill  study  demonstrated
hat both  the  alcohol-based  antiseptic  and  water-
ased antiseptic  lotion  had  a greater  immediate  kill
han a traditional,  alcohol-only  sanitizer,  as  seen
n Table  3. This  comparison  indicates  that  even
he water-based  antiseptic  lotion  is  equivalent  or
uperior to  the  alcohol-based  products  currently
sed in  healthcare  facilities  for  immediate,  broad-
pectrum  kill.
The  beneﬁts  and  drawbacks  of  the  alcohol  san-
tizers currently  used  in  medical  facilities  are  well
nown.  These  sanitizers  provide  rapid  bacterial
ill but  raise  concerns  about  skin  irritation,  com-
liance,  and  ﬂammability  and  have  no  persistent
fﬁcacy.
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The  results  from  this  study  indicate  that  the
water-based antiseptic  lotion  is equivalent  in  rapid,
broad-spectrum  antimicrobial  activity  and  support
the use  of  a  water-based  product  in  healthcare
facilities, as  well  as  in  schools,  homes,  and  other
organizations. A  persistent,  BZT-based  product  may
reduce skin  irritation,  improve  compliance,  elimi-
nate concerns  about  ﬂammability  and  storage,  add
a persistent  effect  to  the  products  in  use,  and  show
increased  efﬁcacy  against  viruses  compared  with
traditional  alcohol  sanitizers.
Additional  clinical  studies  are  necessary  to
determine whether  the  use  of  a  water-based  prod-
uct with  persistence  is  capable  of  reducing  the
transmission of  microorganisms  and  lowering  infec-
tion rates  in  medical  facilities  and  elsewhere.
These results  demonstrate  that  non-alcohol  anti-
septic  products  can  be  just  as  effective  in  the  rapid,
broad-spectrum  reduction  of  microorganisms  that
cause disease,  and  may  provide  signiﬁcant  clinical
advantages  over  alcohol  sanitizers.
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